Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion type Assertion NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_head.
- NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion description "[SRSF2 and U2AF1 along with TET2 (48%) and ASXL1 (38%) are frequently affected by somatic mutations in chronic myelomonocytic leukemia, quite distinctly from the profile seen in juvenile myelomonocytic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_provenance.
- NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion evidence source_evidence_literature NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_provenance.
- NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion SIO_000772 22773603 NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_provenance.
- NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion wasDerivedFrom befree-2016 NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_provenance.
- NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_assertion wasGeneratedBy ECO_0000203 NP996067.RAESFQe_ZEEa03vHF6665o-PR1j0y8D5wIL8bzNF-LhSg130_provenance.